Emerging role of complement system in the induction of neuroinflammation in adenylosuccinate lyase deficiency disorder. Brain, Behavior, & Immunity - Health. 2025; 48:101091.
A new member at the table: Granzyme K as a lymphocyte‐born complement initiator. Clinical and Translational Discovery. 2025; 5(4).
Complement Inhibition Expands the Therapeutic Window of Amyloid-β Immunotherapy in Alzheimer's Disease. DISCOVERY MEDICINE. 2025; 37(198):1409.
Complement System and Adhesion Molecule Skirmishes in Fabry Disease: Insights into Pathogenesis and Disease Mechanisms. International Journal of Molecular Sciences. 2024; 25(22).
C-X-C Motif Chemokine Ligand 9 and Its CXCR3 Receptor Are the Salt and Pepper for T Cells Trafficking in a Mouse Model of Gaucher Disease. International Journal of Molecular Sciences. 2021; 22(23).
An unexpected player in Gaucher disease: The multiple roles of complement in disease development. Seminars in Immunology. 2018; 37:30-42.
Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease. Nature. 2017; 543(7643):108-112.
Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcγRIIB and dectin-1. Nature Medicine. 2012; 18(9):1401-1406.
Functional basis for complement evasion by staphylococcal superantigen-like 7. Cellular Microbiology. 2010; 12(10):1506-1516.
Staphylococcal complement evasion by various convertase-blocking molecules. Journal of Experimental Medicine (JEM). 2007; 204(10):2461-2471.
A regulatory role for the C5a anaphylatoxin in type 2 immunity in asthma. Journal of Clinical Investigation. 2006; 116(3):783-796.
Central Roles of Glucosylceramide in Driving Cancer Pathogenesis. International Journal of Molecular Sciences. 2025; 26(20).
Emerging role of complement system in the induction of neuroinflammation in adenylosuccinate lyase deficiency disorder. Brain, Behavior, & Immunity - Health. 2025; 48:101091.
A new member at the table: Granzyme K as a lymphocyte‐born complement initiator. Clinical and Translational Discovery. 2025; 5(4).
Molecular Diplomacy of Lipids in the War of Immunity: Bridging Rare and Common Disease Mechanisms. International Journal of Molecular Sciences. 2025; 26(12).
Complement Inhibition Expands the Therapeutic Window of Amyloid-β Immunotherapy in Alzheimer's Disease. DISCOVERY MEDICINE. 2025; 37(198):1409.
A zebrafish model of crim1 loss of function has small and misshapen lenses with dysregulated clic4 and fgf1b expression. Frontiers in Cell and Developmental Biology. 2025; 13:1522094.
Complement System and Adhesion Molecule Skirmishes in Fabry Disease: Insights into Pathogenesis and Disease Mechanisms. International Journal of Molecular Sciences. 2024; 25(22).
Immunological harmony: the dynamic influence of cellular and humoral immunity on pregnancy success. Discover Immunity. 2024; 1(1):2.
Embracing the Science of Motherhood: Pregnancy's Transformative Effects on the Central Nervous System and the Radiance of Maternal Hormones and Immune Responses. DISCOVERY MEDICINE. 2023; 35(178):673-696.
Uncovering the Lipid Web: Discovering the Multifaceted Roles of Lipids in Human Diseases and Therapeutic Opportunities. International Journal of Molecular Sciences. 2023; 24(17).
Complement Turning Violent in Ultra-Rare Genetic Disorder. Journal of Immunology. 2023; 210(Supplement_1):153.04-153.04.
Exploring Pro-Inflammatory Immunological Mediators: Unraveling the Mechanisms of Neuroinflammation in Lysosomal Storage Diseases. Biomedicines. 2023; 11(4).
Targeting the Complement-Sphingolipid System in COVID-19 and Gaucher Diseases: Evidence for a New Treatment Strategy. International Journal of Molecular Sciences. 2022; 23(22).
Pre-existing humoral immune comebacks control the development of the severe form of coronavirus disease 2019 in Gaucher patients. Clinical and Translational Discovery. 2022; 2(2):e96.
Acid β-glucosidase insufficiency activates the C-X-C Motif Chemokine Ligand 9/CXCR3 axis leading to T cell mediated inflammation in Gaucher disease. . 2022; 208(1 Supplement):166.01-166.01.
Acid β-glucosidase insufficiency activates the C-X-C Motif Chemokine Ligand 9/CXCR3 axis leading to T cell mediated inflammation in Gaucher disease. Journal of Immunology. 2022; 208(Supplement_1):166.01-166.01.
Fat and Protein Combat Triggers Immunological Weapons of Innate and Adaptive Immune Systems to Launch Neuroinflammation in Parkinson's Disease. International Journal of Molecular Sciences. 2022; 23(3).
The Role of Alpha-Synuclein Autoantibodies in the Induction of Brain Inflammation and Neurodegeneration in Aged Humans. Frontiers in Aging Neuroscience. 2022; 14:902191.
C-X-C Motif Chemokine Ligand 9 and Its CXCR3 Receptor Are the Salt and Pepper for T Cells Trafficking in a Mouse Model of Gaucher Disease. International Journal of Molecular Sciences. 2021; 22(23).
Genetic parkinsonisms and cancer: a systematic review and meta-analysis. Reviews in the Neurosciences. 2021; 32(2):159-167.
Genetic Defects and Pro-inflammatory Cytokines in Parkinson's Disease. Frontiers in Neurology. 2021; 12:636139.